152 related articles for article (PubMed ID: 5527428)
1. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
Curri G
Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
[No Abstract] [Full Text] [Related]
2. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
Koch G
Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
[No Abstract] [Full Text] [Related]
3. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
Fritsch H; Bachmann GW; Lenhard J
Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
[No Abstract] [Full Text] [Related]
4. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
Palagi L; D'Elia M; Lanzara P; Criscione SM
Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
[No Abstract] [Full Text] [Related]
5. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
Langer-Costanzi M
Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
[No Abstract] [Full Text] [Related]
6. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
Caparello O; Contino A; Viola A; Pirro G
Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
[No Abstract] [Full Text] [Related]
7. [First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].
Michel D; Zimmermann W; Nassehi A; Seraphim P
Dtsch Med Wochenschr; 1966 Sep; 91(35):1540-7. PubMed ID: 5917865
[No Abstract] [Full Text] [Related]
8. [Hemodynamic changes following adminstration of dichlorophenylamino-imidazoline hydrochloride in acute and chronic experiments].
Schneider KW; Gattenlöhner W; Müller W
Verh Dtsch Ges Inn Med; 1967; 73():611-6. PubMed ID: 4873599
[No Abstract] [Full Text] [Related]
9. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
Ludwig H
Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
[No Abstract] [Full Text] [Related]
10. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
[No Abstract] [Full Text] [Related]
11. [Organ changes in severe hypertension and the degree to which these can be influenced by medical treatment].
Dorph S; Leth A; Degnbol B; From A
Ugeskr Laeger; 1970 Oct; 132(42):1961-5. PubMed ID: 4990778
[No Abstract] [Full Text] [Related]
12. [Treatment and prognosis of renal hypertension].
Oshima K; Takeda T; Fukuchi S; Abe K; Kajiwara N
Jpn Circ J; 1974 Apr; 38():Suppl:93-7. PubMed ID: 4406378
[No Abstract] [Full Text] [Related]
13. [Effect of hypotensive therapy on kidney function in hypertensive states].
Shershnev VG; Shcherban' NN; Gorodetskiĭ AL
Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250
[No Abstract] [Full Text] [Related]
14. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
Ferreira EB; Eichemberg R; Berlitz MF
Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
[No Abstract] [Full Text] [Related]
15. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
[No Abstract] [Full Text] [Related]
16. [The kidney in essential arterial hypertension: should microalbuminuria excretion be measured?].
García Puig J; Mateos Antón F
Rev Clin Esp; 1995 Jun; 195(6):425-36. PubMed ID: 7644795
[No Abstract] [Full Text] [Related]
17. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
Haan D
Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
[No Abstract] [Full Text] [Related]
18. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
Krämer D; Krause W; Renner H
Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
[No Abstract] [Full Text] [Related]
19. [Changes in heart and kidney function in renovascular hypertension patients with blood flow restored in the renal arteries by transcutaneous intravascular balloon dilatation].
Arabidze GG; Belichenko OI; Kukharchuk VV; Zaruba AIu; Savel'ev VIu
Klin Med (Mosk); 1983 Feb; 61(2):43-6. PubMed ID: 6843057
[No Abstract] [Full Text] [Related]
20. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
Borrello G
Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
